Patient-Helpdesk.com

acorda therapeutics patient assistance program

by Prof. Brendon Stroman Published 1 year ago Updated 1 year ago
image

National Organization for Rare Disorders provides Acorda Therapeutics patient assistance program. NORD offers an one year supply of Zanaflex at no cost to those who are eligible for the program. Eligibility is based off of the following requirements:

Full Answer

See more

image

What is Acorda Therapeutics?

Acorda Therapeutics is a biotechnology company developing therapies for multiple sclerosis, spinal cord injury and other nervous system disorders. The Company's marketed products include AMPYRA (TM) (dalfampridine), a potassium channel blocker approved as a treatment to improve walking in patients with multiple sclerosis (MS), as demonstrated by an improvement in walking speed; and ZANAFLEX CAPSULES (R) (tizanidine hydrochloride), a short-acting drug for the management of spasticity. The Company's pipeline includes a number of products in development for the treatment, regeneration and repair of the spinal cord and brain.

Does Acorda have AMPYRA?

Acorda has established AMPYRA Patient Support Services, a dedicated resource for healthcare professionals and people with MS. Experienced customer care agents will be available to help healthcare professionals process prescriptions, work with insurance carriers to facilitate coverage, and direct patients to available assistance programs.

What is Acorda Therapeutics?

Their specific focus is geared towards developing and providing the best treatment possible for all central nervous system related disorders. Acorda Therapeutics offers tailored therapy programs that are aimed specifically at restoring neurological function and providing relief in conditions such as spinal cord injury, multiple sclerosis, and Spasticity.

How many Americans can't afford medication?

There are over 100 million Americans that either can‚t afford their medication or are struggling to afford their medication. We aim to help each and every American in that situation.

What is AMPYRA 10 mg?

AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg, is the first and only brand prescription medicine indicated to help improve walking in adults with multiple sclerosis (MS). This was demonstrated by an increase in walking speed.

Does APSS cover AMPYRA?

If you are prescribed AMPYRA, APSS can confirm whether your insurance will cover your prescription, and whether you are eligible for our co-pay program. If you have commercial insurance (employer-sponsored or individual) and AMPYRA is covered, you may be eligible for co-pay assistance for AMPYRA where allowed by law.

image
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9